Article
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
BJU international - 1 Nov 2017
McDaniel Andrew S, Ferraldeschi Roberta, Krupa Rachel, Landers Mark, Graf Ryon, Louw Jessica, Jendrisak Adam, Bales Natalee, Marrinucci Dena, Zafeiriou Zafeiris, Flohr Penelope, Sideris Spyridon, Crespo Mateus, Figueiredo Ines, Mateo Joaquin, de Bono Johann S, Dittamore Ryan, Tomlins Scott A, Attard Gerhardt
Abstract excerpt
OBJECTIVES: To use a non-biased assay for circulating tumour cells (CTCs) in patients with prostate cancer (PCa) in order to identify non-traditional CTC phenotypes potentially excluded by conventional detection methods that are reliant on antigen- and/or size-based enrichment. PATIENTS AND METHODS: A total of 41 patients with metastatic castration-resistant PCa (mCRPC) and 20 healthy volunteers were analysed on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.